W. R. Berkley (WRB) has drawn fresh attention after reporting second quarter 2026 revenue of US$3,716.12 million and net income of US$452.26 million, with earnings per share higher than a year earlier.

At a share price of US$73.38, W. R. Berkley has seen its 30 day share price return of 4.04% and 90 day share price return of 10.55% supported by recent earnings and ongoing buybacks, while a 5 year total shareholder return of 156.02% points to sustained longer term compounding.

If you are also weighing other insurance and financial stocks with strong leadership benches, it can be helpful to scan a broader universe of quality businesses through the 19 top founder-led companies

W. R. Berkley now trades above the average analyst price target, yet screens at a sizeable discount to some intrinsic value estimates. Is the recent share price enthusiasm running ahead of fundamentals, or still underrating the business?

Most Popular Narrative: 7% Overvalued

The most followed narrative pegs W. R. Berkley’s fair value at $68.33, which sits below the recent $73.38 share price and frames a mild premium.

Prudent capital management, shown by a growing investment portfolio benefitting from higher new money yields and conservative reserving, is increasing investment income and book value per share, laying a foundation for higher long-term earnings and the potential for resumed share buybacks.

Want to know what keeps that fair value below today’s price? The narrative leans on margin strength, steady earnings and a valuation multiple that quietly does the heavy lifting.

Result: Fair Value of $68.33 (OVERVALUED)

However, W. R. Berkley still faces risks from softening commercial and reinsurance pricing, as well as the possibility that current earnings expectations for 2026 and 2027 prove too optimistic.

Another View on W. R. Berkley’s Valuation

The narrative model suggests W. R. Berkley is modestly overvalued around $73.38 compared with a fair value of $68.33. A second lens, our DCF model, points in the opposite direction and indicates the stock is trading well below an assessed future cash flow value of $125.55, which screens as undervalued. Which framework do you trust more for your own thesis?

For a closer look at the assumptions behind this cash flow view, and how sensitive it might be to shifts in growth or margins, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out W. R. Berkley for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 56 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals around W. R. Berkley leave you unsure, take a closer look at the underlying data now and shape your own view with the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond W. R. Berkley?

If W. R. Berkley has sharpened your focus on quality, now is the time to widen your watchlist with a few targeted stock ideas that fit your goals.

• Spot potential value opportunities early and size them up against your thesis using the 56 high quality undervalued stocks.
• Strengthen your focus on resilience by checking companies highlighted in the 89 resilient stocks with low risk scores.
• Hunt for quality that flies under the radar through the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.